Organs on Chips Market
Organs on Chips Market by Type (Liver, Heart, Lung, Other Organ Types), by Application (Drug Discovery, Toxicology Research, Other Applications), by End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other End Users), by Region (Latin America, North America, Europe, Asia Pacific) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)
|Forecast Years for Organs on Chips Market:||2022 - 2028|
|Historical Years for Organs on Chips Market:||2016 - 2021|
|Revenue 2021 for Organs on Chips Market:||USD 28.1 Million|
|Revenue 2028 for Organs on Chips:||USD 125.7 Million|
|Revenue CAGR (2022 - 2028) for Organs on Chips Market :||28.1%|
|Fastest Growing Region (2022 - 2028) for Organs on Chips Market:||Asia Pacific|
|Largest Region (2021) for Organs on Chips Market:||North America|
Global Organs on Chips Market is valued at USD 28.1 Million in 2021 and is projected to attain a value of USD 125.7 Million by 2028 at a CAGR of 28.1% during the forecast period, 2022–2028. The growing focus on developing alternatives to animal testing models, a significant increase in research funding and venture capital investments for the development of Organs on Chips, technological advancements and new product launches, a growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and a growing need for early detection of drug toxicity to minimize financial costs are all driving the growth of Organs on Chips Market.
In the face of the COVID-19 pandemic, the scientific community and the biopharmaceutical sector have mobilised at breakneck speed. As a result, Organs on Chips has been established as one of the most promising and go-to technologies in the creation of vaccines and medications for the treatment of infection that are currently undergoing clinical trials. The imitate lung-chip, for example, was utilised to provide preclinical insights into the efficacy of hydroxychloroquine for COVID-19 in March 2020 as part of the World Health Organization's (WHO) Research and Development Blueprint response to the COVID-19 outbreak.
Advancements in Technology
Factors driving the Organs on Chips Market include the demand for alternatives to animal testing, the need for early identification of drug toxicity, as well as new product releases and technological breakthroughs. For example, in December 2020, CN Bio and the University of Melbourne worked to enhance respiratory complications therapy using lung-on-a-chip technology in patients who had recovered from COVID-19. Furthermore, in October 2020, BioVox launched an initiative to promote Organs on Chips technology as a means of improving in vitro research models and eliminating animal testing.
The demand for customised medicine and the wide range of applications for Organs on Chips technology outside of the pharmaceutical industry are two important reasons driving market expansion. The intricacy of Organs on Chips models, on the other hand, may stifle market growth over the foreseeable period.
Global Organs on Chips Market is segmented by Organ Type (Liver, Heart, Lung, and Other Organ Types). Based on Application (Drug Discovery, Toxicology Research, and Other Applications), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End Users). Based on Region, the Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Below tree is interactive. You can click the nodes to get more information.
Lung Application is Expected to Grow Fastest During the Forecast Period
On a microchip, lung-on-chip technology is a complicated three-dimensional replica of a living, breathing human lung. This technology, which is made up of human lung and blood vessel cells, can predict nanoparticle absorption and simulate the inflammatory response induced by microbial infections. The device can also be used to assess environmental contaminants, aerosolized treatments absorption, and the safety and efficacy of novel medications. It is anticipated that it will become a viable alternative to animal experimentation. Lung-on-chip also offers an unique in vitro approach to drug screening by imitating the intricate mechanical and biochemical behaviours of a human lung, thanks to the combination of micro manufacturing techniques and contemporary tissue engineering.
North America Is Expected To Dominate the Market During The Forecast Period
North America is predicted to account for the greatest share of the market in 2020 and to grow at the fastest CAGR, followed by Europe. The availability of new and advanced Organs on Chips models in the market, favourable government initiatives in terms of funding and programmes for basic drug development and research, and the presence of key pharmaceutical companies are all factors that contribute to this market's large share and rapid growth.
Some key players operating in the market are Mimetas (Netherlands), Emulate (US), InSphero (Switzerland), Ascendance Bio (US), CN Bio (UK), TissUse (Germany), Kirkstall (UK), HUREL (HUREL) (US), SynVivo (US), AxoSim (US), and Nortis (US).
Organs on Chips Market is segmented as follows:
Regions & Countries Covered
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
Organs on Chips Market is tabulated as follows:
Frequently Asked Questions
the global demand for Organs on Chips
in terms of revenue?
The global Organs on Chips valued at USD 28.1 Million in 2020 and is expected to reach USD 125.7 Million in 2028 growing at a CAGR of 28.1%
are the prominent players
in the market?
The prominent players in the market are AxoSim Inc., BiomimX SRL, Elveflow, Emulate Inc., Hurel Corporation, InSphero AG, MIMETAS BV, Nortis Inc., Tara Biosystems Inc., and TissUse GmbH.
At what CAGR is the market projected to grow within the forecast period?
The market is project to grow at a CAGR of 28.1% between 2021 and 2028.
the driving factors
fueling the growth of the market.
The driving factors of the Organs on Chips include
- Advancements in Technology
region accounted for the
largest share in the market?
North America was the leading regional segment of the Organs on Chips in 2020.